Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer

BACKGROUND: The effectiveness of immune checkpoint inhibitors in treating gallbladder cancer (GBC) remains unsatisfactory. Recently, several new immune checkpoints have been identified. However, investigations exploring these immune checkpoints in GBC are limited. In this study, we aim to investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xing, Peng, Yaorong, He, Gui, Ye, Huilin, Liu, Liqiang, Zhou, Qixian, Shi, Juanyi, Fu, Sha, Wang, Jie, Zhou, Zhenyu, Li, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571407/
https://www.ncbi.nlm.nih.gov/pubmed/37828574
http://dx.doi.org/10.1186/s12967-023-04589-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571407/
https://www.ncbi.nlm.nih.gov/pubmed/37828574
http://dx.doi.org/10.1186/s12967-023-04589-3

Ejemplares similares